LIN-003

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLIN-003
Drug Alias NameLx-R1LIN-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEsophageal and Gastric Varices
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLinXis BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLinXis BV
Active IndicationsN/A
Inactive IndicationsEsophageal and Gastric Varices

Other Information

ATC CodeN/A
Related LinksN/A